Financial Daily from THE HINDU group of publications Friday, Oct 22, 2004 |
||
|
|
||
|
Corporate Results
-
Pharmaceuticals Nicholas Piramal Q2 net up at Rs 54.39 crore; stock split okayed Our Bureau
Mumbai , Oct. 21 DRUG company Nicholas Piramal India Ltd (NPIL) has posted a net profit of Rs 54.39 crore for the quarter ended September 30, as against Rs 50.52 crore for the same quarter in the previous year. Total income (net of excise and sales tax) has increased to Rs 360.92 crore (Rs 356. 97 crore). Further, the company informed the BSE that the group has posted a net profit of Rs 55.77 crore for the quarter ended September 30, as against Rs 52.13 crore last year. Total income (net of excise and sales tax) has increased Rs 382.12 crore (Rs 382.12 crore). The board of Nicholas Piramal, at its meeting here on Thursday, also approved a 5:1 split of the company's shares. The company's shares will therefore, have a face value of Rs 2 , a company communiqué said.
More Stories on : Pharmaceuticals
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2004, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|